Bladder Cancer

Papers
(The TQCC of Bladder Cancer is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives9
Clinical Trials Corner Issue 8(1)7
Iatrogenic Causes of Urothelial Cancer of the Upper Urinary Tract and Bladder7
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer7
Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models7
Impact of Intestinal Urinary Diversion on the Risk of Fracture and Loss of Bone Mass: A Systematic Review6
Quality of Life and Anxiety in Patients with First Diagnosed Non-Muscle Invasive Bladder Cancer Who Receive Adjuvant Bladder Therapy6
No Association Between BCG Instillations and COVID-19 Incidence in a Dutch Non-Muscle Invasive Bladder Cancer Cohort6
Urologists and Advanced Practice Providers Evaluating Hematuria6
Antibiotics and BCG5
Clinical Trials Corner Issue 9(2)4
Management of bladder cancer in kidney transplant recipients: A narrative review4
CD274 (PD-L1) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract4
Differences in Quality of Life Between Men and Women who Undergo Bladder Preservation with Trimodality Therapy4
Standard vs extended lymphadenectomy for muscle invasive bladder cancer4
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not Matter4
Comparison of Robotic vs Open Cystectomy: A Systematic Review4
Evaluation of the Effects of Opium on the Expression of SOX2 and OCT4 in Wistar Rat Bladder4
Clinical Trials Corner Issue 10(2)3
Systematic Review and Meta-Analysis of Cisplatin Based Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer3
A New Standard of Care for Bladder Cancer3
Clinical Trials Corner Issue 7(3)3
Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog Breed3
Organoid models in bladder cancer: From bench to bedside?3
Non-Muscle Invasive Bladder Cancer: Many More Patients Die With It Than Of It3
Systemic induction therapy in patients with locally advanced or node-positive urothelial carcinoma: Evaluating treatment outcomes2
Immune Checkpoint Inhibitors in Metastatic Bladder and Other Solid Malignancies: How Long is Enough?2
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with Atezolizumab2
Challenging Cases in Urothelial Cancer: Case 272
Loss of Cxcr2 in Myeloid Cells Promotes Tumour Progression and T Cell Infiltration in Invasive Bladder Cancer2
Efficacy of Surgery on the Primary Tumour in Patients with Metastatic Bladder Cancer: A Comprehensive Review2
Y Chromosome Loss and Bladder Cancer2
Commentary on Novitas LCD2
Challenging Cases in Urothelial Cancer: Case 262
A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer2
Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors2
Molecular Basis of Tumorigenesis of Bladder Cancer and Emerging Concepts in Developing Therapeutic Targets2
Challenging Cases in Urothelial Cancer: Case 332
0.049185991287231